These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 22234600)

  • 1. FP-CIT SPECT evaluation: time to go beyond visual assessment!
    Skanjeti A; Angusti T; Margheron M; Iudicello M; Podio V
    Eur J Nucl Med Mol Imaging; 2012 Apr; 39(4):727-8. PubMed ID: 22234600
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical markers of early nigrostriatal neurodegeneration in idiopathic rapid eye movement sleep behavior disorder.
    Rupprecht S; Walther B; Gudziol H; Steenbeck J; Freesmeyer M; Witte OW; Günther A; Schwab M
    Sleep Med; 2013 Nov; 14(11):1064-70. PubMed ID: 23948220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular imaging (SPECT and PET) in the evaluation of patients with movement disorders.
    Gerasimou GP; Aggelopoulou TC; Costa DC; Gotzamani-Psarrakou A
    Nucl Med Rev Cent East Eur; 2006; 9(2):147-53. PubMed ID: 17304479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SPECT imaging evaluation in movement disorders: far beyond visual assessment.
    Badiavas K; Molyvda E; Iakovou I; Tsolaki M; Psarrakos K; Karatzas N
    Eur J Nucl Med Mol Imaging; 2011 Apr; 38(4):764-73. PubMed ID: 21125269
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison between a dual-head and a brain-dedicated SPECT system in the measurement of the loss of dopamine transporters with [123I]FP-CIT.
    Varrone A; Sansone V; Pellecchia MT; Amboni M; Salvatore E; De Michele G; Filla A; Barone P; Pappatà S; Salvatore M
    Eur J Nucl Med Mol Imaging; 2008 Jul; 35(7):1343-9. PubMed ID: 18283454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is the time ripe to adopt semiquantitative analysis of SPECT evaluation in movement disorders as a standard?
    Caobelli F; Paghera B; Giubbini R
    Eur J Nucl Med Mol Imaging; 2011 Mar; 38(3):596-7. PubMed ID: 21210107
    [No Abstract]   [Full Text] [Related]  

  • 7. Combined visual and semi-quantitative assessment of
    Ueda J; Yoshimura H; Shimizu K; Hino M; Kohara N
    Neurol Sci; 2017 Jul; 38(7):1187-1191. PubMed ID: 28389938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reproducibility of a standardized quantitative analysis using fixed regions of interest to differentiate movement disorders on 123I-FP-CIT SPECT.
    Stokkel MP; Dibbets-Schneider P; Koestering E; Dragoiescu C; Blokland KA
    J Nucl Med Technol; 2007 Mar; 35(1):21-6. PubMed ID: 17337653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dopamine transporter imaging with [(123)I]FP-CIT SPECT: potential effects of drugs.
    Booij J; Kemp P
    Eur J Nucl Med Mol Imaging; 2008 Feb; 35(2):424-38. PubMed ID: 17968545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Automated quantification with BRASS reduces equivocal reporting of DaTSCAN (123I-FP-CIT) SPECT studies.
    Pencharz DR; Hanlon P; Chakravartty R; Navalkissoor S; Quigley AM; Wagner T; Wagner T
    Nucl Med Rev Cent East Eur; 2014; 17(2):65-9. PubMed ID: 25088104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Semiquantitative slab view display for visual evaluation of 123I-FP-CIT SPECT.
    Buchert R; Hutton C; Lange C; Hoppe P; Makowski M; Bamousa T; Platsch G; Brenner W; Declerck J
    Nucl Med Commun; 2016 May; 37(5):509-18. PubMed ID: 26703759
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 123I-FP-CIT SPECT imaging of the dopaminergic state. Visual assessment of dopaminergic degeneration patterns reflects quantitative 2D operator-dependent and 3D operator-independent techniques.
    Kahraman D; Eggers C; Holstein A; Schneider C; Pedrosa DJ; Dietlein M; Kobe C; Timmermann L; Schmidt M
    Nuklearmedizin; 2012; 51(6):244-51. PubMed ID: 22526237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extrastriatal dopaminergic and serotonergic pathways in Parkinson's disease and in dementia with Lewy bodies: a
    Pilotto A; Schiano di Cola F; Premi E; Grasso R; Turrone R; Gipponi S; Scalvini A; Cottini E; Paghera B; Garibotto V; Rizzetti MC; Bonanni L; Borroni B; Morbelli S; Nobili F; Guerra UP; Perani D; Padovani A
    Eur J Nucl Med Mol Imaging; 2019 Jul; 46(8):1642-1651. PubMed ID: 31098748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Development of a Striatal and Skull Phantom for Quantitative
    Ishiguro M; Uno M; Miyazaki T; Kataoka Y; Toyama H; Ichihara T
    Nihon Hoshasen Gijutsu Gakkai Zasshi; 2018; 74(2):124-132. PubMed ID: 29459538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Global scaling for semi-quantitative analysis in FP-CIT SPECT.
    Kupitz D; Apostolova I; Lange C; Ulrich G; Amthauer H; Brenner W; Buchert R
    Nuklearmedizin; 2014; 53(6):234-41. PubMed ID: 25209576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessing the accuracy and reproducibility of computer-assisted analysis of (123) I-FP-CIT SPECT using BasGan (V2).
    Skanjeti A; Angusti T; Iudicello M; Dazzara F; Delgado Yabar GM; Trevisiol E; Podio V
    J Neuroimaging; 2014; 24(3):257-65. PubMed ID: 23323544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Direct comparison of FP-CIT SPECT and F-DOPA PET in patients with Parkinson's disease and healthy controls.
    Eshuis SA; Jager PL; Maguire RP; Jonkman S; Dierckx RA; Leenders KL
    Eur J Nucl Med Mol Imaging; 2009 Mar; 36(3):454-62. PubMed ID: 19037637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Measurement of [123I]FP-CIT binding to the dopamine transporter (DAT) in healthy mouse striatum using dedicated small animal SPECT imaging: feasibility, optimization and validation.
    Greco A; Zannetti A; Pappatà S; Albanese S; Coda AR; Ragucci M; Nardelli A; Brunetti A; Cuocolo A; Salvatore M
    Q J Nucl Med Mol Imaging; 2018 Mar; 62(1):112-117. PubMed ID: 26329495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Brain parenchyma sonography and 123I-FP-CIT SPECT in Parkinson's disease and essential tremor.
    Doepp F; Plotkin M; Siegel L; Kivi A; Gruber D; Lobsien E; Kupsch A; Schreiber SJ
    Mov Disord; 2008 Feb; 23(3):405-10. PubMed ID: 18067184
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improved visual [(123)I]FP-CIT SPECT interpretation for evaluation of parkinsonism by visual rating of parametric distribution volume ratio images.
    Meyer PT; Winz OH; Dafotakis M; Werner CJ; Krohn T; Schäfer WM
    Q J Nucl Med Mol Imaging; 2011 Jun; 55(3):301-9. PubMed ID: 21532542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.